Tag archive

BIOCAD

Russian antitumor drugs first time received a registration certificate in Europe

in Pharmaceutical News
Russian antitumor drugs first time received a registration certificate in Europe

Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of ICM d.o.o partner and is valid for 5 years. The first deliveries shall start in June 2020. Registration processes started in December 2018. During this time, a thorough examination of the drugs documentary and samples quality was carried out. According to the law, the first commercial series of the drug for sale is…

Keep Reading

BIOCAD started working on mRNA vaccine against coronavirus

in Pharmaceutical News
BIOCAD started working on mRNA vaccine against coronavirus

Biotechnological company BIOCAD has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April. According to Dmitry Morozov, BIOCAD CEO, today the whole world is working on the search for coronavirus treatment: “By now, 66 companies around the world have announced the development of drugs against SARS-COV-19,…

Keep Reading

Go to Top